Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results

Cyclacel Pharmaceuticals, Inc. (CYCC) Posts Q4 Loss of 19c/Share

March 25, 2014 4:05 PM EDT

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) reported Q4 EPS of ($0.19), $0.14 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $299 thousand versus the consensus estimate of $90 thousand.

For earnings history and earnings-related data on Cyclacel Pharmaceuticals, Inc. (CYCC) click here.... More